Abstract
Background and aims: The economic burden resulting from diabetic retinopathy (DR) consumes a major portion of resources allocated for health-care services. Cost-effectiveness of various interventions on DR and its complications has relatively been well explored in developed countries, but these are almost absent in developing countries. The present study was undertaken to assess the cost-effectiveness of medical intervention in patients with DR.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
